Page last updated: 2024-09-04

ym 872 and Cerebral Arterial Diseases

ym 872 has been researched along with Cerebral Arterial Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Håberg, A; Haraldseth, O; Hjelstuen, M; Takahashi, M; Yamaguchi, T	1

Other Studies

1 other study(ies) available for ym 872 and Cerebral Arterial Diseases

Article	Year
Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion. Brain research, 1998, Nov-16, Volume: 811, Issue:1-2 Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Drug Evaluation, Preclinical; Imidazoles; Linear Models; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA	1998

Article

Year

Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion.

Brain research, 1998, Nov-16, Volume: 811, Issue:1-2

Topics: Animals; Arterial Occlusive Diseases; Cerebral Arterial Diseases; Drug Evaluation, Preclinical; Imidazoles; Linear Models; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA

1998